All In MedTech

Device Trial Radar · NCT06098482

An Investigation to Validate Speech Perception Assessment for Adult Cochlear Recipients Using a Mobile Research App

A Prospective, Repeated-measures Investigation to Validate Digital Speech Perception Endpoints in Adult Cochlear Implant Recipients Using the Mobile Research App: a Master Umbrella Investigation

Last checked: Nov 19, 2026Latest source record: Oct 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

46

Planned (sponsor's estimate)

Start

Feb 5, 2024

Primary completion

May 2, 2027

Study completion May 2, 2027

Sponsor

Lead sponsor
CochlearNot on our public-company list
Sponsor type
Industry
First posted
Oct 24, 2023

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Basic science
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The study is a feasibility, prospective, repeated-measures, multi-country, multi-centre, study of the Mobile Research App to measure and validate speech perception endpoints in adult cochlear implant recipients.

Conditions

  • Hearing Loss

Interventions

  • Mobile Research App (MRA)Device

    The MRA (research tool) is a platform used for the delivery of speech perception material in-clinic outside the sound booth or in the home of the hearing-impaired recipients. The MRA speech testing module delivers speech material via streaming to the single implanted ears of cochlear implant recipients. The recipient listens to the speech material and responds with what was heard via the app. Speech is streamed via Bluetooth from the iOS device to the sound processor of the CI-recipient.

  • SOC/validated delivery of the speech perception test materialOther

    This involves the delivery of speech perception test material in the sound booth in a clinic.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percent correct performance for the test and retest runs of speech perception abilityTime frame: 1 day - immediately post screening.

Locations

4 sites in 3 countries. Site status is shown where the registry gives one.

  • Denver Research and Technology Labs

    Lone Tree, Colorado

  • HEARnet Clinical Studies

    Melbourne, Victoria, Australia

  • European Institute for Otorhinolaryngology (EIORL) ENT department Sint-Augustinus Antwerp

    Antwerp, Antwerp, Belgium

1 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.